4//SEC Filing
VANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LP 4
Accession 0001209191-10-048880
CIK 0001316175other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:06 PM ET
Size
15.2 KB
Accession
0001209191-10-048880
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2010-09-30+12,000→ 12,000 total(indirect: By: Annette Bianchi)Exercise: $4.19Exp: 2020-09-30→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period from July 9, 2010.
- [F2]VantagePoint Venture Associates IV, LLC has the sole power to exercise the option, and sole voting and investment power with respect to the shares underlying the option. Ms. Bianchi disclaims beneficial ownership thereof except to the extent of her pecuniary interest therein.
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001267585
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:06 PM ET
- Size
- 15.2 KB